178 related articles for article (PubMed ID: 11331071)
1. Cannabinoid-induced alterations in brain disposition of drugs of abuse.
Reid MJ; Bornheim LM
Biochem Pharmacol; 2001 Jun; 61(11):1357-67. PubMed ID: 11331071
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines.
Arellano AL; Papaseit E; Romaguera A; Torrens M; Farré M
CNS Neurol Disord Drug Targets; 2017; 16(5):554-566. PubMed ID: 28412920
[TBL] [Abstract][Full Text] [Related]
3. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
4. Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain.
Bornheim LM; Kim KY; Li J; Perotti BY; Benet LZ
Drug Metab Dispos; 1995 Aug; 23(8):825-31. PubMed ID: 7493549
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.
Ryan D; Drysdale AJ; Pertwee RG; Platt B
Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463
[TBL] [Abstract][Full Text] [Related]
6. Δ
Silveira MM; Adams WK; Morena M; Hill MN; Winstanley CA
J Psychiatry Neurosci; 2017 Mar; 42(2):131-138. PubMed ID: 28245177
[TBL] [Abstract][Full Text] [Related]
7. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
8. Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
Varvel SA; Wiley JL; Yang R; Bridgen DT; Long K; Lichtman AH; Martin BR
Psychopharmacology (Berl); 2006 Jun; 186(2):226-34. PubMed ID: 16572263
[TBL] [Abstract][Full Text] [Related]
9. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
Todd SM; Arnold JC
Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
Hložek T; Uttl L; Kadeřábek L; Balíková M; Lhotková E; Horsley RR; Nováková P; Šíchová K; Štefková K; Tylš F; Kuchař M; Páleníček T
Eur Neuropsychopharmacol; 2017 Dec; 27(12):1223-1237. PubMed ID: 29129557
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity in the composition of marijuana seized in California.
Burgdorf JR; Kilmer B; Pacula RL
Drug Alcohol Depend; 2011 Aug; 117(1):59-61. PubMed ID: 21288662
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic and nonpsychotropic cannabis derivatives inhibit human 5-HT(3A) receptors through a receptor desensitization-dependent mechanism.
Xiong W; Koo BN; Morton R; Zhang L
Neuroscience; 2011 Jun; 184():28-37. PubMed ID: 21477640
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid use is enhanced by stress and changes conditioned stress responses.
Hodebourg R; Meyerink ME; Crow AD; Reichel CM; Kalivas PW; Garcia-Keller C
Neuropsychopharmacology; 2022 Apr; 47(5):1037-1045. PubMed ID: 35145212
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Taffe MA; Creehan KM; Vandewater SA
Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
[TBL] [Abstract][Full Text] [Related]
15. Effects on variable-interval performance in rats of delta 9-tetrahydrocannabinol and cannabidiol, separately and in combination.
Zuardi AW; Karniol IG
Braz J Med Biol Res; 1983 Jul; 16(2):141-6. PubMed ID: 6317104
[TBL] [Abstract][Full Text] [Related]
16. Characterization of P-glycoprotein inhibition by major cannabinoids from marijuana.
Zhu HJ; Wang JS; Markowitz JS; Donovan JL; Gibson BB; Gefroh HA; Devane CL
J Pharmacol Exp Ther; 2006 May; 317(2):850-7. PubMed ID: 16439618
[TBL] [Abstract][Full Text] [Related]
17. Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain.
Tripathi HL; Vocci FJ; Brase DA; Dewey WL
Alcohol Drug Res; 1987; 7(5-6):525-32. PubMed ID: 3620017
[TBL] [Abstract][Full Text] [Related]
18. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetics and the pharmacodynamics of cannabinoids.
Lucas CJ; Galettis P; Schneider J
Br J Clin Pharmacol; 2018 Nov; 84(11):2477-2482. PubMed ID: 30001569
[TBL] [Abstract][Full Text] [Related]
20. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
Parker LA; Kwiatkowska M; Burton P; Mechoulam R
Psychopharmacology (Berl); 2004 Jan; 171(2):156-61. PubMed ID: 13680081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]